Clinical Trial Update: Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and pharmacokinetics of two single doses of NNC128-0000-2011 in haemophilia A or haemophilia B patients; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• NNC128-0000-2011

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 1 | Status: COMPLETED